Assessment of serum levels and placental bed tissue expression of IGF-1, bFGF, and PLGF in patients with placenta previa complicated with placenta accreta spectrum disorders

References

• Mohamed Zakria AE-M, Abd El-Kader El-Tabakh A, Ahmed Mahmoud Amer M. Uterine artery doppler and placental morphological features as predictors of peripartum complications in placenta previa and placenta previaaccreta. J Al-Azhar Med J. 2019;48(4):1–10. doi:10.21608/amj.2019.64952.
   Google Scholar
• Wang F, Zhang L, Zhang F, et al. First-trimester serum PIGF is associated with placenta accreta. Placenta. 2020;101:39–44. doi:10.1016/j.placenta.2020.08.023.
   PubMed Web of Science ®Google Scholar
• Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int J Womens Health. 2020;12:1033–1045. doi:10.2147/IJWH.S224191.
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang S. Potential serum biomarkers in prenatal diagnosis of placenta accreta spectrum. Front Med (Lausanne). 2022;9:860186. doi:10.3389/fmed.2022.860186.
   PubMed Web of Science ®Google Scholar
• Arakaza A, Zou L, Zhu J. Placenta accreta spectrum diagnosis challenges and controversies in current obstetrics: a review. Int J Womens Health. 2023;15:635–654. doi:10.2147/IJWH.S395271.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Moffett A, Burton GJ. Placental implantation disorders. Obstet Gynecol Clin North Am. 2020;47(1):117–132. doi:10.1016/j.ogc.2019.10.002.
   PubMed Web of Science ®Google Scholar
• Park HS, Cho HS. Management of massive hemorrhage in pregnant women with placenta previa. Anesth Pain Med (Seoul). 2020;15(4):409–416. doi:10.17085/apm.20076.
   PubMedGoogle Scholar
• Jauniaux E, Dimitrova I, Kenyon N, et al. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth. Ultrasound Obstet Gynecol. 2019;54(5):643–649. doi:10.1002/uog.20244.
   PubMed Web of Science ®Google Scholar
• Bardin N, Murthi P, Alfaidy N. Normal and pathological placental angiogenesis. Biomed Res Int. 2015;2015:354359. doi:10.1155/2015/354359.
   PubMed Web of Science ®Google Scholar
• Knöfler M, Haider S, Saleh L, et al. Human placenta and trophoblast development: key molecular mechanisms and model systems. Cell Mol Life Sci. 2019;76(18):3479–3496. doi:10.1007/s00018-019-03104-6.
   PubMed Web of Science ®Google Scholar
• Woods L, Perez-Garcia V, Hemberger M. Regulation of placental development and its impact on fetal growth-new insights from mouse models. Front Endocrinol (Lausanne). 2018;9:570. doi:10.3389/fendo.2018.00570.
   PubMed Web of Science ®Google Scholar
• Biberoglu E, Kirbas A, Daglar K, et al. Serum angiogenic profile in abnormal placentation, the journal of maternal-fetal & neonatal medicine: the official journal of the European association of perinatal medicine, the federation of Asia and Oceania perinatal societies, the international society of. Perinatal Obstet. 2016;29(19):3193–3197.
   Google Scholar
• Ortega MA, Saez MA, Fraile-Martínez O, et al. Increased angiogenesis and lymphangiogenesis in the placental villi of women with chronic venous disease during pregnancy. IJMS. 2020;21(7):2487. doi:10.3390/ijms21072487.
   Google Scholar
• Faraji A, Akbarzadeh-Jahromi M, Bahrami S, et al. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum. J Obstet Gynaecol. 2022;42(5):900–905. doi:10.1080/01443615.2021.1955337.
   PubMedGoogle Scholar
• Ma M, Zhou QJ, Xiong Y, et al. Preeclampsia is associated with hypermethylation of IGF-1 promoter mediated by DNMT1. Am J Trans Res. 2018;10(1):16–39.
   PubMed Web of Science ®Google Scholar
• Alessandrini L, Aryananda R, Ariani G, et al. The correlation between serum levels and placental tissue expression of PLGF and sFLT-1 and the FIGO grading of the placenta accreta spectrum disorders. J Matern-Fetal Neonatal Med. 2023;36(1):2183744. doi:10.1080/14767058.2023.2183744.
   PubMed Web of Science ®Google Scholar
• Ceci C, Atzori MG, Lacal PM, et al. Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models. IJMS. 2020;21(4):1388. doi:10.3390/ijms21041388.
   Google Scholar
• Jacobo SM, Kazlauskas A. Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels. J Biol Chem. 2015;290(10):6349–6360. doi:10.1074/jbc.M114.634154.
   PubMed Web of Science ®Google Scholar
• Eelen G, Treps L, Li X, et al. Basic and therapeutic aspects of angiogenesis updated. Circ Res. 2020;127(2):310–329. doi:10.1161/CIRCRESAHA.120.316851.
   PubMed Web of Science ®Google Scholar
• Sweeney M, Foldes G. It takes two: endothelial-perivascular cell cross-talk in vascular development and disease. Front Cardiovasc Med. 2018;5:154. doi:10.3389/fcvm.2018.00154.
   PubMed Web of Science ®Google Scholar
• Herrick EJ, Bordoni B. Embryology, placenta. Treasure Island (FL): StatPearls Publishing LLC; 2022.
   Google Scholar
• Giudice LC, Mark SP, Irwin JC. Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface. J Reprod Immunol. 1998;39(1–2):133–148. doi:10.1016/s0165-0378(98)00018-7.
   PubMed Web of Science ®Google Scholar
• He X, Zhao L, Yue L, et al. The relationship between IGF1 and the expression spectrum of miRNA in the placenta of preeclampsia patients. Ginekol Pol. 2019;90(10):596–603. doi:10.5603/GP.2019.0096.
   PubMed Web of Science ®Google Scholar
• Bartels HC, Postle JD, Downey P, et al. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018;2018:1507674–1507611. doi:10.1155/2018/1507674.
   PubMed Web of Science ®Google Scholar
• Lyell DJ, Faucett AM, Baer RJ, et al. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol. 2015;35(8):570–574. doi:10.1038/jp.2015.40.
   PubMed Web of Science ®Google Scholar
• Chrusciel M, Rekawiecki R, Ziecik AJ, et al. mRNA and protein expression of FGF-1, FGF-2 and their receptors in the porcine umbilical cord during pregnancy. Folia Histochem Cytobiol. 2010;48(4):572–580. doi:10.2478/v10042-010-0073-4.
   PubMed Web of Science ®Google Scholar
• Yun YR, Won JE, Jeon E, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng. 2010;2010:218142. doi:10.4061/2010/218142.
   PubMedGoogle Scholar
• Hecht JL, Baergen R, Ernst LM, 3rd, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33(12):2382–2396. doi:10.1038/s41379-020-0569-1.
   PubMed Web of Science ®Google Scholar
• Yang HX, Yan J, Liu XX[, et al. The standardized terminology and clinical diagnosis on “placenta accrete spectrum disorders” in China. Zhonghua fu chan ke za zhi. 2021;56(6):377–379.
   PubMedGoogle Scholar
• Wang N, Shi D, Li N, et al. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa. Ann Med. 2021;53(1):2041–2049. doi:10.1080/07853890.2021.1999492.
   PubMed Web of Science ®Google Scholar
• Zhang F, Gu M, Chen P, et al. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio. Placenta. 2022;124:48–54. doi:10.1016/j.placenta.2022.05.009.
   PubMed Web of Science ®Google Scholar
• Faralli I, Del Negro V, Chinè A, et al. Placenta accreta spectrum (PAS) disorder: ultrasound versus magnetic resonance imaging. Diagnostics. 2022;12(11):2769. doi:10.3390/diagnostics12112769.
   Web of Science ®Google Scholar
• Cavalli C, Maggi C, Gambarini S, et al. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders. J Perinat Med. 2022;50(3):277–285. doi:10.1515/jpm-2021-0334.
   PubMed Web of Science ®Google Scholar
• Kashyap S, Zeidler JD, Chini CCS, et al. Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease. Cell Signal. 2020;73:109698. doi:10.1016/j.cellsig.2020.109698.
   PubMed Web of Science ®Google Scholar
• Halari CD, Nandi P, Jeyarajah MJ, et al. Decorin production by the human decidua: role in decidual cell maturation. Mol Hum Reprod. 2020;26(10):784–796. doi:10.1093/molehr/gaaa058.
   PubMed Web of Science ®Google Scholar
• Santos ED, Moindjie H, Sérazin V, et al. Preimplantation factor modulates trophoblastic invasion throughout the decidualization of human endometrial stromal cells, reproductive biology, and endocrinology. RB&E. 2021;19(1):96.
   PubMed Web of Science ®Google Scholar
• Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, et al. MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. AJR Am J Roentgenol. 2017;208(1):214–221. doi:10.2214/AJR.16.16281.
   PubMed Web of Science ®Google Scholar
• Martinez-Fierro ML, Garza-Veloz I, Castañeda-Lopez ME, et al. Evaluation of the effect of the fibroblast growth factor type 2 (FGF-2) administration on placental gene expression in a murine model of preeclampsia induced by L-NAME. Int J Mol Sci. 2022;23(17):10129. doi:10.3390/ijms231710129.
   PubMed Web of Science ®Google Scholar
• Martinez-Fierro ML, Hernadez-Delgadillo GP, Flores-Mendoza JF, et al. Fibroblast growth factor type 2 (FGF2) administration attenuated the clinical manifestations of preeclampsia in a murine model induced by L-NAME. Front Pharmacol. 2021;12:663044. doi:10.3389/fphar.2021.663044.
   PubMed Web of Science ®Google Scholar
• Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol. 2011;204(5):411.e1–411.e11. doi:10.1016/j.ajog.2010.12.027.
   PubMed Web of Science ®Google Scholar
• Uyanıkoğlu H, İncebıyık A, Turp AB, et al. Serum angiogenic and anti-angiogenic markers in pregnant women with placenta percreta. Balkan Med J. 2018;35(1):55–60. doi:10.4274/balkanmedj.2016.1890.
   PubMed Web of Science ®Google Scholar
• Park C, Chen X, Yang JR, et al. Differential requirements for mRNA folding partially explain why highly expressed proteins evolve slowly. Proc Natl Acad Sci USA. 2013;110(8):E678–686. doi:10.1073/pnas.1218066110.
   PubMed Web of Science ®Google Scholar